Post Training Evaluation

Thank you for attending this learning activity.  Please take a few moments to evaluation this training.
IMPORTANT!!
Once you complete the post-training evaluation and click FINISHED and you will be redirected to a webpage to print or save your continuing education certificate.
If you have difficulties completing this survey, contact Amy Wales at amy.wales@miccsi.org.

Demographics

Question Title

* 1. Personal Information

Question Title

* 3. Please choose your role:

Question Title

* 4. After attending this session, please indicate your confidence in managing pain care for people with Opioid Use Disorder (OUD).

Question Title

* 5. On a scale of 1-5, how would you rate this training overall? (Scale: 1=very dissatifed & 5=very satisfied)

Question Title

* 6. What did you like most about this session?

Question Title

* 7. What did you like least about this session?

Question Title

* 8. Do you have specific suggestions as to how this learning activity might be improved?

Question Title

* 9. Did you feel the content was:

Question Title

* 10. Please provide your impressions about Eva Quirion, FNP, PhD's presentation by rating each category on a scale of 1-5 where:

1=VERY POOR
2=POOR
3=AVERAGE
4=GOOD
5=EXCELLENT

  1 2 3 4 5
Knowledge of presenter
Overall rating of topic/presentation
This topic was relevant to my role

Question Title

* 11. Did the presentations and materials meet the following objectives?
1. Review the definition of Opioid Use Disorder (OUD) and SUD.
2. Review the types of treatment.
3. Review of case study and application of information.

Question Title

* 12. After attending this session, do you intend to change your practice behavior?

Question Title

* 13. After attending this session, I have the ability to apply the skills learned in my role.

Question Title

* 14. What new abilities/strategies have you gained from this training?

Question Title

* 15. Was the information/material presented in this learning activity free from commercial bias?

Question Title

* 16. If you answered no to the above question, please explain.

Question Title

* 17. Additional Comments:

T